| Date Filed | Type | Description |
| 06/21/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 100,000 options to buy
@ $2.04, valued at
$204k
|
|
| 06/12/2020 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 7,500 options to buy
@ $6.17, valued at
$46.3k
|
|
| 01/29/2020 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 30,000 options to buy
@ $7.54, valued at
$226.2k
Disposed/sold 30,000 options to buy
@ $4.09, valued at
$122.7k
Disposed/sold 25,000 options to buy
@ $3.02, valued at
$75.5k
Disposed/sold 30,000 options to buy
@ $2.9, valued at
$87k
Disposed/sold 6,250 options to buy
@ $2.74, valued at
$17.1k
Disposed/sold 42,000 options to buy
@ $2.18, valued at
$91.6k
|
|
| 07/15/2019 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $5.74, valued at
$143.5k
|
|
| 06/05/2019 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 7,500 options to buy
@ $6.53, valued at
$49k
|
|
| 01/25/2019 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 42,000 options to buy
@ $2.18, valued at
$91.6k
|
|
| 06/14/2018 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $8.99, valued at
$224.8k
|
|
| 06/07/2018 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 14,000 options to buy
@ $1.48, valued at
$20.7k
|
|
| 02/13/2018 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $2.9, valued at
$87k
|
|
| 07/28/2017 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 6,500 options to buy
@ $1.27, valued at
$8.3k
|
|
| 06/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/07/2016 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 13,000 options to buy
@ $4.8, valued at
$62.4k
|
|
| 04/07/2016 |
3
| KISHBAUCH MICHAEL D (Director) has filed a Form 3 on CATABASIS PHARMACEUTICALS INC |
| 01/27/2016 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $7.54, valued at
$226.2k
|
|
| 06/11/2015 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC|
Txns:
| Granted 20,000 options to buy
@ $6.72, valued at
$134.4k
|
|
| 03/04/2015 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC|
Txns:
| Granted 15,342 options to buy
@ $6.65, valued at
$102k
|
|
| 01/30/2015 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Granted 10,000 options
@ $5.25, valued at
$52.5k
|
|
| 12/04/2014 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $13.24, valued at
$331k
|
|
| 11/07/2014 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Granted 20,000 options to buy
@ $3.87, valued at
$77.4k
|
|
| 08/15/2014 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 150,000 shares
@ $9.36, valued at
$1.4M
Sold 158,000 shares
@ $9.36, valued at
$1.5M
Sold 133,125 shares
@ $9.36, valued at
$1.2M
Sold 54,687 shares
@ $9.75, valued at
$533.2k
Exercised 150,000 options to buy
@ $4.82, valued at
$723k
Exercised 158,000 options to buy
@ $1.05, valued at
$165.9k
Exercised 133,125 options to buy
@ $3.28, valued at
$436.7k
Exercised 54,687 options to buy
@ $7.59, valued at
$415.1k
|
|
| 06/19/2014 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC|
Txns:
| Granted 20,000 options to buy
@ $4.47, valued at
$89.4k
|
|
| 06/11/2014 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 371,937 shares
@ $7.75, valued at
$2.9M
Exercised 371,937 options to buy
@ $3.1, valued at
$1.2M
|
|
| 12/19/2013 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $3.02, valued at
$75.5k
|
|
| 10/09/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/12/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/12/2013 |
3
| KISHBAUCH MICHAEL D (Director) has filed a Form 3 on PROGENICS PHARMACEUTICALS INC |
| 01/13/2012 |
4
| KISHBAUCH MICHAEL D (CEO and President) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 198,306 shares
@ $12.6335, valued at
$2.5M
Exercised 81,309 options to buy
@ $1.6, valued at
$130.1k
Exercised 116,997 options to buy
@ $4, valued at
$468k
|
|
| 01/11/2012 |
4
| KISHBAUCH MICHAEL D (CEO and President) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 90,209 shares
@ $10.0149, valued at
$903.4k
Sold 8,900 shares
@ $12.5021, valued at
$111.3k
Exercised 90,209 options to buy
@ $1.6, valued at
$144.3k
Exercised 8,900 options to buy
@ $1.6, valued at
$14.2k
|
|
| 12/14/2011 |
4
| KISHBAUCH MICHAEL D (CEO and President) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 125,000 options to buy
@ $7.59, valued at
$948.8k
|
|
| 06/24/2011 |
4
| KISHBAUCH MICHAEL D (CEO and President) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 10,200 shares
@ $7.505, valued at
$76.6k
Sold 5,500 shares
@ $7.5095, valued at
$41.3k
Sold 1,800 shares
@ $7.5, valued at
$13.5k
Exercised 10,200 options to buy
@ $1.6, valued at
$16.3k
Exercised 5,500 options to buy
@ $1.6, valued at
$8.8k
Exercised 1,800 options to buy
@ $1.6, valued at
$2.9k
|
|
|